“Radical innovation and a true democratization of medical care are within reach, but only if we consumers demand it.”
Dr. Eric Topol brings power to the people in his new book The Creative Destruction of Medicine. This is the best guide I’ve seen to help consumers as well as professionals navigate the uncharted territory of personalized medicine. Read more »
ALS may be the most deadly disease many people have never heard of. Amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig’s disease affects at least 30,000 people in the United States and 450,000 people worldwide. It is a progressive neurodegenerative disorder that causes muscle atrophy, paralysis, and ultimately death with a three to five year survival rate. Read more »
“Now is the time. We’ve proven that it works in the clinic…multiple times and multiple ways. Now is the time that virtual reality (VR) needs to move out of the lab and into every clinic and hospital to deliver the clear benefits.” So began a pointed rallying call from Dr. Walter Greenleaf, who along with Jaron Lanier, pioneered the use of VR in clinical settings.
Known mainly for failing to live up to its potential, a recent conference “Medicine Meets Virtual Reality” (MMVR) highlighted how this label is fading…fast. Read more »
A recent discussion at Swissnex San Francisco provided insights into the challenge of making robots more human. This goal holds profound implications for healthcare and the treatment of injuries to the body and brain. Read more »
G. Steven Burrill is biotech’s unofficial spokesperson. Involved in creating industry stalwarts such as Genentech, Amgen and Chiron, he’s expanded his influence through a $1B+ venture capital fund and a successful merchant bank.
His annual State of Biotech report is eagerly anticipated by the entire industry.
This year’s address underscored the value of “Understanding how the world is, how it’s going to change and how to build companies for the future. There’s no magic formula…just perspective.” Read more »
Dr. Ida Sim detailed a buzz-making project at the Silicon Valley Health Tech’s “mega-meetup”.
Sim is a Professor of Medicine at the University of California, San Francisco, where she directs the Center for Clinical and Translational Informatics and is Co-Director of Biomedical Informatics for UCSF’s Clinical and Translational Science Institute. She’s also the co-founder of Open mHealth.
Open mHealth was founded on the principle that there are “certain things we shouldn’t have to build over and over ” for mobile health applications.
The official topic at the BIOMEDevice conference was “speed to market”.
However, four leaders from diverse parts of the medical device industry offered solid and practical advice for all aspects of device design and development.
When asked to name the greatest challenge for device manufacturers in getting products to market, the leaders offered answers similar to those heard elsewhere in life sciences and healthcare. Read more »
With more than ten billion neurons, each connected thousands of times, the brain has been described as the ultimate social networking tool.
Two of the world’s top neuroscientists took center stage at the Bay Area Science Festival to discuss this complex topic, co-sponsored by Swissnex SF.
David Eagleman is a neuroscientist and director of the Laboratory for Perception and Action at Baylor College of Medicine. He’s also a popular author whose most recent book is Incognito: The Secret Lives of the Brain.
Henry Markram is director of the Blue Brain Project at École Polytechnique Fédérale de Lausanne (EPFL) as well as a coordinator of the Human Brain Project. Read more »
Age Structure by Race and Ethnicity
Under the direction of Senior Research Scholar Adele Hayutin, the Stanford Center on Longevity has produced a study of California’s changing demographics. The report includes demographic profiles of more than 200 communities in California, illustrating shifts in age structure and changes in ethnic and racial composition. The project was developed for the California State Library to facilitate greater understanding of how demographic characteristics differ across the state and to help inform decisions regarding changing needs of local communities.
“Dramatic changes in the financial markets have largely eliminated sell side research coverage for all but the largest and most actively traded stocks. This leaves some of the most promising equity investment
opportunities inaccessible to most investors. Enter OMP Research.”
OneMedPlace announces their first issue of OMP Research, following promising small public healthcare and life science companies that they think are significantly undervalued.
Companies profiled in this issue:
DataTrak – [DATA.PK] Clinical trials software management
Novadaq – [NDQ.TO] Surgical optics and diagnostics
PLC Medical – [PLCSF.OB] Renal care
Vasomedical – [VASO.PK] New treatments for cardiovascular diseases
Wound Management – [WNDM.PK] Wound healing technologies
Dowload the report: 2011_ResearchReportNovember
© 2008 - 2011 ESSINOVA, the Essinova design and "Essinova - The Essence of Innovation" are registered service marks of Song Essinova, LLC. "For the Well Being of Humanity" is service mark of Song Essinova, LLC.
About Us | Our Services | Privacy Policy | Terms of Use | Contact Us
